TXMD
TherapeuticsMD, Inc.
+0.01 (+0.41%)2.19USD4.8K成交股數25.3M市值–本益比(近四季)7.8股價營收比-8.7%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 869K-9% | 724K+84% | 893K+63% | 784K+235% | 952K+204% | 393K-22% | 547K-1132% | 234K-46% | 313K | 502K | −53K | 437K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | 502K | −53K | 437K |
| 毛利率 | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 1.6M | 1.4M | 2.7M | 1.5M | 1.6M | 1.1M | 1.6M | 1.6M | 1.3M | 1.5M | 1.6M | 2.8M |
| 營業利益 | −816K+17% | −723K-44% | −1.6M+37% | −862K-69% | −695K-39% | −1.3M-20% | −1.1M-36% | −2.8M+13% | −1.1M | −1.6M | −1.8M | −2.5M |
| 營業利益率 | -93.9% | -99.9% | -173.8% | -109.9% | -73.0% | -326.0% | -207.3% | -1,191.9% | -364.9% | -320.9% | 3,345.3% | -565.7% |
| 稅後淨利 | 155K-72% | 95K-115% | −619K+2% | 152K-114% | 551K-175% | −653K-26% | −609K-82% | −1.1M-55% | −734K | −883K | −3.4M | −2.4M |
| 淨利率 | 17.8% | 13.1% | -69.3% | 19.4% | 57.9% | -166.2% | -111.3% | -465.8% | -234.5% | -175.9% | 6,373.6% | -552.4% |
| 稀釋 EPS | 0.01-80% | 0.01-117% | -0.050% | 0.01-111% | 0.05-183% | -0.060% | -0.05-84% | -0.09-63% | -0.06 | -0.06 | -0.32 | -0.24 |
| 稀釋股數 | 11.6M | 11.6K | 11.6M | 11.6M | 11.6M | 11.6K | 11.5M | 11.5M | 11.5M | 10.4K | 10.7M | 10.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 9.2M | 8.4M | 7.5M | 7.1M | 6.1M | 5.7M | 5.0M | 5.2M | 4.3M | 4.3M | 49.3M | 13.7M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 37.5M | 37.6M | 37.7M | 38.7M | 38.5M | 38.2M | – | 40.1M | – | 43.3M | 50.5M | 53.7M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 10.4M | 10.6M | 10.8M | 11.2M | 11.2M | 11.5M | – | 12.5M | – | 14.0M | 22.4M | 22.5M |
| 股東權益 | 27.1M | 27.0M | 26.9M | 27.4M | 27.3M | 26.7M | 27.1M | 27.7M | 28.7M | 29.3M | 28.1M | 31.2M |
| 負債比 | 27.7% | 28.2% | 28.6% | 29.0% | 29.1% | 30.1% | – | 31.0% | – | 32.4% | 44.4% | 41.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 944K+35% | – | – | – | 699K | – | – | −229K | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | 95K | 94K | 97K | 96K | 96K | 95K | 96K | 180K | 133K | – | – | 128K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 3.0M
| 美國 | 1.8M | 59.3% | +59.6% |
|---|---|---|---|
| 美國以外 | 1.2M | 40.7% | +92.8% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 3.0M | +71.6% | −569K | -18.8% | -0.05 | – |
| FY2024 | 1.8M | +35.3% | −2.2M | -123.9% | -0.19 | – |
| FY2023 | 1.3M | -98.1% | −10.3M | -789.4% | -0.99 | – |
| FY2022 | 70.0M | +2619.1% | 112M | 160.1% | 11.96 | – |
| FY2021 | 2.6M | -96.0% | −172M | -6,700.9% | -21.66 | −143M |
| FY2020 | 64.9M | +30.7% | −184M | -282.9% | -0.67 | −160M |
| FY2019 | 49.6M | +208.4% | −176M | -354.8% | -0.72 | −168M |
| FY2018 | 16.1M | – | −133M | -823.7% | -0.59 | −107M |